Cytokine storm and sepsis disease pathogenesis

被引:1018
作者
Chousterman, Benjamin G. [1 ,2 ]
Swirski, Filip K. [3 ]
Weber, Georg F. [4 ]
机构
[1] Hop Univ Lariboisiere St Louis, AP HP, Dept Anesthesie Reanimat, Paris, France
[2] Hop St Louis, Inserm U1160, Paris, France
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Imaging, Ctr Syst Biol, Boston, MA 02114 USA
[4] Univ Erlangen Nurnberg, Dept Surg, Erlangen, Germany
关键词
Cytokine; Inflammation; Innate immunity; Sepsis; Endothelium; TUMOR-NECROSIS-FACTOR; ANTAGONIST GENE POLYMORPHISM; BETA-GLUCAN RECEPTOR; SEPTIC SHOCK; INTERFERON-GAMMA; DOUBLE-BLIND; INFLAMMATORY RESPONSE; MONOCLONAL-ANTIBODY; TGF-BETA; T-CELLS;
D O I
10.1007/s00281-017-0639-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infectious diseases are a leading cause of death worldwide. Sepsis is a severe clinical syndrome related to the host response to infection. The severity of infections is due to an activation cascade that will lead to an autoamplifying cytokine production: the cytokine storm. Cytokines are a broad category of relatively small proteins (<40 kDa) that are produced and released with the aim of cell signaling. Our understanding of the processes that trigger this tremendous amount of cytokine production has made dramatic progress over the last decades, but unfortunately, these findings could not translate yet into effective treatments; so far, all clinical trials targeting cytokine production or effects failed. This review aims to summarize the pathophysiology of the cytokine storm; to describe the type, effects, and kinetics of cytokine production; and to discuss the therapeutic challenges of targeting cytokines. New promising therapeutic strategies focusing on the endothelium, as a source and a target of cytokines, are described.
引用
收藏
页码:517 / 528
页数:12
相关论文
共 125 条
  • [1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
    ABRAHAM, E
    WUNDERINK, R
    SILVERMAN, H
    PERL, TM
    NASRAWAY, S
    LEVY, H
    BONE, R
    WENZEL, RP
    BALK, R
    ALLRED, R
    PENNINGTON, JE
    WHERRY, JC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
  • [2] Critical Care 1 Critical care and the global burden of critical illness in adults
    Adhikari, Neill K. J.
    Fowler, Robert A.
    Bhagwanjee, Satish
    Rubenfeld, Gordon D.
    [J]. LANCET, 2010, 376 (9749) : 1339 - 1346
  • [3] The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
    Aird, WC
    [J]. BLOOD, 2003, 101 (10) : 3765 - 3777
  • [4] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [5] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [6] ALEXANDER HR, 1992, SURGERY, V112, P188
  • [7] Septic shock
    Annane, D
    Bellissant, E
    Cavaillon, JM
    [J]. LANCET, 2005, 365 (9453) : 63 - 78
  • [8] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [9] [Anonymous], TODAYS LIFE SCI
  • [10] [Anonymous], SEMIN ONCOL S9